Healix Health Services has added a bespoke benefit to its corporate healthcare trust plan to support employees needing professional assessment and treatment for their neurodevelopmental disorders.
Healix says its service assists employees in seeking diagnoses and treatment by facilitating access to specialists, including giving them the freedom to choose and use the best practitioners for their particular situation.
Employers can support their personnel for recognised disorders including dyslexia, dysgraphia, autism, and attention deficit hyperactivity disorder (ADHD) through Healix’s product according to the provider.
Healix says the benefit was created with the needs of both employers and employees in mind, with a heavy emphasis on clinical results. To help employees with neurodiverse conditions and their families, it gives companies the option of choosing between two levels of care: assessment alone or assessment and therapy.
Healix CEO Ian Talbot says: “15 per cent of people in the UK are estimated to be neurodivergent and thus potentially facing difficulties in the workplace as they attempt to fit into a world that is not catered for them. With the strong focus on employee wellbeing and health in the last few years, it’s important for us to develop innovative ways for employers to support their neurodivergent employees, and promote neurodiversity.
“Delivering flexible and tailored healthcare benefits that promote a supportive workplace for our clients is at the heart of our commitment. By helping employees access initial referrals and treatment for neurodevelopmental disorders, employers can better support their employees while benefitting from the diverse and unique skillset that they have to offer.
“Neurodiversity has long been overlooked by the healthcare and benefits sector and providing this level of bespoke support for workers marks a vital step towards assisting employees and their families to flourish both at home and at work. We’re extremely proud to bring this offering to our clients and look forward to continuing our work towards more supportive healthcare benefits.”
